As of November 6, 2026, Aura Biosciences, Inc. has reported one exit or restructuring plan to the SEC on Form 8-K under Item 2.05, the latest filed on August 11, 2026. No WARN notice under its name is on file in the states covered here (Form 8-K, August 11, 2026).
Who owns Aura Biosciences, Inc.?
12 companies announced layoffs this week.
Companies cutting jobs this week. Before you unlock: the company, the number of employees and what is inside. After: every way we found to reach the company. No individual is named in a layoff.
| Artiva Biotherapeutics, Inc. | announced layoffs | |
| Eos Energy Enterprises, Inc. | announced layoffs | |
| SOUNDHOUND AI, INC. | announced layoffs | |
| Portillo's Inc. | announced layoffs | |
| Acumen Pharmaceuticals, Inc. | announced layoffs of about 52 employees |
Is this your company?
Owed money by them or selling to them? See the free Snapshot of Aura Biosciences, Inc.
Free to see. No signup.
Aura Biosciences, Inc. reported 1 exit or restructuring plan on Form 8-K under Item 2.05. Each fact below is the filing's own sentence, quoted and linked. No WARN notice under this company's name is on file in the states covered here.
Did Aura Biosciences have layoffs in 2026? What its filings say
Aura Biosciences, Inc. (CIK 1501796) reported 1 exit or restructuring plan to the SEC on Form 8-K under Item 2.05. The sentences below are quoted from the filings as written.
Form 8-K filed 2026-08-11
Expected charges
The total cash payments and costs related to the Realignment and reducing the workforce are estimated to be approximately $2.9 million to $3.2 million, with a significant majority of these amounts expected to be paid in the third quarter of 2026.
Also on the record for Aura Biosciences, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| October 27, 2026 | Stake report, Schedule 13G, by BlackRock, Inc. | 5.03% of the class | 5%+ stakes | Source |
| October 1, 2026 | Stake report, Schedule 13G, by ForGrowth III PA B.V. | 5.1% of the class | 5%+ stakes | Source |
| August 14, 2026 | Stake report, Schedule 13G, by LONG FOCUS CAPITAL MANAGEMENT, LLC | 4.9% of the class | 5%+ stakes | Source |
| August 14, 2026 | Stake report, Schedule 13G/A, by Frazier Life Sciences Public Fund, L.P. | 5.6% of the class | 5%+ stakes | Source |
| August 12, 2026 | Stake report, Schedule 13G/A, by Adage Capital Management, L.P. | 8.44% of the class | 5%+ stakes | Source |
| August 11, 2026 | Leadership change: Amy Elazzouzi appointed, Senior Vice President, Finance, and 1 more | — | Leadership changes | Source |
| July 27, 2026 | Stake report, Schedule 13G/A, by BlackRock, Inc. | 4.4% of the class | 5%+ stakes | Source |
| July 8, 2026 | Leadership change: Jeremy Bender appointed, Director | — | Leadership changes | Source |
| May 12, 2026 | Stake report, Schedule 13G, by Chen Yu | 9.9% of the class | 5%+ stakes | Source |
| May 11, 2026 | Stake report, Schedule 13D/A, by Matrix Capital Management Company LP | — | 5%+ stakes | Source |
| May 4, 2026 | Leadership change: Natalie Holles appointed, Chief Executive Officer | — | Leadership changes | Source |
| February 17, 2026 | Stake report, Schedule 13G/A, by Rajesh Parekh, Ph.D. | 3.335% of the class | 5%+ stakes | Source |
Keep reading
More on Aura Biosciences, Inc. and the records around it.
Aura Biosciences, Inc. elsewhere on the record
- 5%+ stake filings Oct 2026
- Leadership changes Aug 2026
- Who owns it
Companies that share a holder
- Matrix Capital Management Company LP also filed stake reports on 2 other companies: Zentalis Pharmaceuticals, Inc. (Jan 2026), Maze Therapeutics, Inc. (Nov 2025)
- ForGrowth III PA B.V. also filed stake reports on 4 other companies: Vor Biopharma Inc. (Dec 2025), Crescent Biopharma, Inc. (Dec 2025), Astria Therapeutics, Inc. (Nov 2025)
- LONG FOCUS CAPITAL MANAGEMENT, LLC also filed stake reports on 8 other companies: STANDARD BIOTOOLS INC. (Aug 2026), BICYCLE THERAPEUTICS PLC (May 2026), ONITY GROUP INC. (May 2026)
Watch Aura Biosciences, Inc.
Get an email when Aura Biosciences, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
What do you want to do with Aura Biosciences, Inc.?
Want the whole picture on Aura Biosciences, Inc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Aura Biosciences, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Aura Biosciences, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
12 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
The newest 12 of 17 records.
Tools for this story
Each opens in a new tab, filled in for Aura Biosciences, Inc.. With no account yet, you sign up free and land on the result.
Public companies must also report to the SEC, on Form 8-K under Item 2.05, when they commit to an exit or restructuring plan that will cost them material charges, which is how most large layoffs and closures by listed companies are disclosed. Those filings are national, so they cover companies in every state. Each sentence shown from one is quoted exactly and linked to the filing; where a filing does not state a figure, none is shown.
Where this comes from
Employers covered by the federal WARN Act, and by the stricter laws some states add, must give written notice before a mass layoff or a site closure. The state labor department publishes those notices. Every row here is one of them, taken from that state's own published file and linked to it, so each figure can be checked at the source.
A notice states the employer, the location, the number of employees affected, and when the layoff or closure takes effect. It does not state a reason, and neither does this page. Where a company also appears in SEC filings under the same name and in the same state, its recorded fundraising is shown alongside, as a matter of record rather than as an explanation. New Jersey and Pennsylvania list a notice under the month it was posted or received, not the day, so their notices show a month. Tennessee gives the county rather than the city.
Related
- Intel Corporation: 177 jobs, Oct 2026 layoff notice within 90 days (2026-10-22)
- Artiva Biotherapeutics, Inc.: 131 jobs, Oct 2026 layoff notice within 90 days (2026-10-27)
- Avidity Biosciences, Inc.: 40 jobs, Oct 2026 layoff notice within 90 days (2026-10-29)
- Kaiser: 147 jobs, San Diego, CA and more, Sep 2026 layoff notice within 90 days (2026-09-21)
- Constellis, LLC: 256 jobs, Sep 2026 layoff notice within 90 days (2026-09-29)
- Cayuga Home for Children, dba Cayuga Centers: 5 WARN notices, 114 employees, Oct 2026 layoff notice within 90 days (2026-10-06)
Cite this page
https://mentionfox.com/layoffs/aura-biosciences